Citadel Advisors’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-15,631
| Closed | -$67K | – | 10204 |
|
|
2019
Q3 | $67K | Buy |
+15,631
| New | +$56.7K | ﹤0.01% | 8633 |
|
|
2019
Q2 | – | Sell |
-13,757
| Closed | -$24K | – | 10258 |
|
|
2019
Q1 | $24K | Sell |
13,757
-45,569
| -77% | -$63K | ﹤0.01% | 9037 |
|
|
2018
Q4 | $50K | Sell |
59,326
-56,402
| -49% | -$67.3K | ﹤0.01% | 8493 |
|
|
2018
Q3 | $164K | Buy |
115,728
+77,829
| +205% | +$85.2K | ﹤0.01% | 8344 |
|
|
2018
Q2 | $31K | Buy |
+37,899
| New | +$36.6K | ﹤0.01% | 8557 |
|
|
2018
Q1 | – | Sell |
-22,980
| Closed | -$23K | – | 9066 |
|
|
2017
Q4 | $23K | Buy |
+22,980
| New | +$26K | ﹤0.01% | 7812 |
|
|
2017
Q3 | – | Sell |
-17,968
| Closed | -$33K | – | 8339 |
|
|
2017
Q2 | $33K | Buy |
+17,968
| New | +$23.9K | ﹤0.01% | 7188 |
|
|
2016
Q3 | – | Sell |
-16,458
| Closed | -$24K | – | 8050 |
|
|
2016
Q2 | $24K | Sell |
16,458
-2,604
| -14% | -$3.02K | ﹤0.01% | 6564 |
|
|
2016
Q1 | $19K | Buy |
+19,062
| New | +$32.8K | ﹤0.01% | 6483 |
|
Citadel Advisors's CVRS Position: Q4 2019 in Review
Citadel Advisors sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 15,631 shares — an estimated $67K sold.
Citadel Advisors first reported a position in CVRS in Q1 2016 and held it in 9 quarters. The position peaked at $164K in Q3 2018. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.
- Citadel Advisors reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
- Citadel Advisors sold 15,631 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $67K.
- Citadel Advisors first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2016 and held it in 9 quarters.
- Citadel Advisors's CORINDUS VASCULAR ROBOTICS, INC position peaked at $164K in Q3 2018.
- 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.